CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)
about
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabineCytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape.CD28-B7 costimulatory blockade by CTLA4Ig delays the development of retrovirus-induced murine AIDS.Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome.Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus.Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory moleculesThe role of CD4 T cells in the pathogenesis of murine AIDS.3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.Mycobacterium avium complex infection in mice: lack of exacerbation after LP-BM5 murine leukemia virus infection.Immunotherapy of murine retrovirus-induced acquired immunodeficiency by CD4 T regulatory cell depletion and PD-1 blockadeUp-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis.Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 miceEvidence that the murine AIDS defective virus does not encode a superantigen.Endogenous Mtv-encoded superantigens are not required for development of murine AIDS.Apoptosis by CD95 (Fas)-dependent and -independent mechanisms in Peyer's patch lymphocytes in murine retrovirus-induced immunodeficiency syndromeStudies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virusModulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania majorSelective Involvement of the Checkpoint Regulator VISTA in Suppression of B-Cell, but Not T-Cell, Responsiveness by Monocytic Myeloid-Derived Suppressor Cells from Mice Infected with an Immunodeficiency-Causing RetrovirusCellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice.CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy.B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome.Delayed progression of a murine retrovirus-induced acquired immunodeficiency syndrome in X-linked immunodeficient mice.In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiencyAdoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organsMyristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cellsMurine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cellsIn murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages.Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiencyExpression of defective virus and cytokine genes in murine AIDSts1, a temperature-sensitive mutant of Moloney murine leukemia virus TB, can infect both CD4+ and CD8+ T cells but requires CD4+ T cells in order to cause paralysis and immunodeficiencyCytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome.Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains.Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice.
P2860
Q28476738-38DC152A-FCA8-4447-B95C-6678BEBAC5A0Q33683425-C1548BE2-F9D9-46B2-8F9A-FCFA8DB935D8Q33784744-8B10DD88-C057-4D3C-B48E-47E8C1C283B3Q33851104-A3962188-A479-4081-AB0D-495987718DEAQ33859375-D1A86D94-A8C9-4068-8BDC-898D139FA67AQ33932705-F606DD1B-F9E4-4E8C-ACC2-167DD16F171BQ34249277-CF5CAE60-11E3-433D-8CB4-D7E814605C33Q34354116-5F724433-EF11-4852-BB8A-36ABB284977AQ34651531-22E2A5F4-DF63-47DD-9F18-DFBB7C053071Q35252215-9EEC8CDB-770E-422F-8ED1-CCEBE8415F6DQ35263086-5332F6C1-490E-4212-A686-DB80031142C9Q35480762-A83D5B83-7A00-4A22-B50A-F4889453F859Q35599342-31492E69-64A4-42A3-AD8D-F202937392A8Q35794840-13E5CB76-28F5-4319-AB6A-D31F1CD4A01AQ35841216-1B302958-2068-4056-B047-0D13D81EA9F3Q35853091-36457143-84DA-4DC5-A541-3A3CF7471C42Q35872775-4EA8A6FB-9386-4DB5-A732-431BE0B8D700Q35874133-412B7161-805C-4F4C-9B67-145EC235D68EQ35881027-95D7B639-CD81-4C61-B145-39B09957EB26Q35883083-746F1C6D-B43D-46A5-8EF4-4C18AA5C2389Q35973689-FD4D8145-6248-40C4-BB68-213886624B26Q36079223-DEFA88C1-FCCB-492A-BA0C-6882C6A4E320Q36161438-C69E74B2-314C-49FC-9290-72E5879BC168Q36231341-01399181-136C-4B03-9033-767BB6159032Q36350250-6AADE8D1-AC51-4385-A139-DAFCCE0E9B1EQ36361476-95E5559E-0B76-446F-8FC3-F23ED005FFCBQ36364205-B5FA9FD6-5676-4BC8-8FEB-ED4F601B3CDFQ36483852-F481F352-1F4F-4735-850B-46E37E444042Q36607445-7AD00240-EF5B-4AB2-AA14-DD3448D91E3FQ36623252-AC03FFA1-FC91-4615-A760-F88A08FB7073Q36630276-84C58627-CB0A-4EDD-855C-1F53D95B8F7EQ36634970-763337B2-EE50-4F6B-8B55-0EE2F6BB822BQ36635147-2340196D-0EC4-4EB4-9C23-19C6040767EEQ36636592-09001C8E-492D-451C-B5AD-AFB9E144540BQ36641771-D15EBC95-45F4-4D3D-930C-98B1D9D603FEQ36680224-ABEE2DE1-D801-41F3-BF9F-88BC846BB0EBQ36696698-6AC3585A-611E-48B8-A8B6-AEC51976661AQ36697749-F7D0AF33-1C3B-4C90-8657-34D2DBC743A2Q36781641-B07BE262-A840-43AB-926D-17D8F420EB57Q36797299-20EEBA72-DECF-4B46-AA16-4B6E2C5704D9
P2860
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@ast
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@en
type
label
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@ast
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@en
prefLabel
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@ast
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@en
P2093
P2860
P356
P1476
CD4+ T cells are required for ...... unodeficiency syndrome (MAIDS)
@en
P2093
D E Mosier
K L Elkins
R A Yetter
R M Buller
T N Fredrickson
P2860
P304
P356
10.1084/JEM.168.2.623
P407
P577
1988-08-01T00:00:00Z